| MolName | (2S)-N-(1,3-benzodioxol-5-yl)-2-[(1R)-cyclohex-3-en-1-yl]-2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]-[(2-methylphenyl)methyl]amino]acetamide |
| MolecularFormula | C31H34N4O4S |
| Smiles | Cc1c(CN([C@@H]([C@H]2CC=CCC2)C(Nc(cc2)cc3c2OCO3)=O)C(CSc2nc(C)cc(C)n2)=O)cccc1 |
| InChI | InChI=1S/C31H34N4O4S/c1-20-9-7-8-12-24(20)17-35(28(36)18-40-31-32-21(2)15-22(3)33-31)29(23-10-5-4-6-11-23)30(37)34-25-13-14-26-27(16-25)39-19-38-26/h4-5,7-9,12-16,23,29H,6,10-11,17-19H2,1-3H3,(H,34,37)/t23-,29-/m0/s1 |
| InChIK | RESXFIGTGVOVSK-IADCTJSHSA-N |
| TotalMolweight | 558.701 |
| Molweight | 558.701 |
| MonoisotopicMass | 558.230076 |
| CLogP | 5.1462 |
| CLogS | -6.43 |
| H Acceptors | 8 |
| H Donors | 1 |
| TotalSurfaceArea | 428.89 |
| Relative PSA | 0.23437 |
| PolarSurfaceArea | 118.95 |
| Druglikeness | 0.65288 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | |
| Shape Index | 0.4 |
| Fragments | 1 |
| Non HAtoms | 40 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 2 |
| Rotatable Bond | 9 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 18 |
| Sp3Atoms | 14 |
| Symmetricatoms | 3 |
| Amides | 2 |
| Aromatic Nitrogens | 2 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (2S)-N-(1,3-benzodioxol-5-yl)-2-[(1R)-cyclohex-3-en-1-yl]-2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]-[(2-methylphenyl)methyl]amino]acetamide | 2 - (2S)-N-(1,3-benzodioxol-5-yl)-2-[(1R)-cyclohex-3-en-1-yl]-2-[[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]-[(2-methylphenyl)methyl]amino]acetamide